Aziyo Biologics Stock Revenue
Aziyo Biologics fundamentals help investors to digest information that contributes to Aziyo Biologics' financial success or failures. It also enables traders to predict the movement of Aziyo Stock. The fundamental analysis module provides a way to measure Aziyo Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aziyo Biologics stock.
Aziyo |
Aziyo Biologics Company Revenue Analysis
Aziyo Biologics' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Aziyo Biologics Revenue | 49.19 M |
Most of Aziyo Biologics' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aziyo Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Aziyo Biologics reported 49.19 M of revenue. This is 99.36% lower than that of the Health Care Equipment & Supplies sector and 98.07% lower than that of the Health Care industry. The revenue for all United States stocks is 99.48% higher than that of the company.
Aziyo Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aziyo Biologics' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aziyo Biologics could also be used in its relative valuation, which is a method of valuing Aziyo Biologics by comparing valuation metrics of similar companies.Aziyo Biologics is currently under evaluation in revenue category among its peers.
Aziyo Fundamentals
| Return On Equity | -7.75 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (0.70) % | |||
| Operating Margin | (0.50) % | |||
| Current Valuation | 40.69 M | |||
| Shares Outstanding | 11.92 M | |||
| Shares Owned By Insiders | 2.18 % | |||
| Shares Owned By Institutions | 70.44 % | |||
| Number Of Shares Shorted | 68.02 K | |||
| Price To Book | 13.34 X | |||
| Price To Sales | 1.29 X | |||
| Revenue | 49.19 M | |||
| Gross Profit | 19.22 M | |||
| EBITDA | (22.38 M) | |||
| Net Income | (32.9 M) | |||
| Cash And Equivalents | 16.49 M | |||
| Cash Per Share | 1.21 X | |||
| Total Debt | 34.89 M | |||
| Debt To Equity | 3.50 % | |||
| Current Ratio | 1.00 X | |||
| Book Value Per Share | (1.36) X | |||
| Cash Flow From Operations | (21.43 M) | |||
| Short Ratio | 3.98 X | |||
| Earnings Per Share | (2.18) X | |||
| Target Price | 10.5 | |||
| Number Of Employees | 151 | |||
| Beta | -0.18 | |||
| Market Capitalization | 23.72 M | |||
| Total Asset | 68.84 M | |||
| Retained Earnings | (137.99 M) | |||
| Working Capital | 8.08 M | |||
| Z Score | -2.62 | |||
| Net Asset | 68.84 M |
Pair Trading with Aziyo Biologics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aziyo Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aziyo Biologics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Exelon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Exelon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Exelon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Exelon to buy it.
The correlation of Exelon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exelon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exelon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Exelon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Aziyo Stock
If you are still planning to invest in Aziyo Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aziyo Biologics' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |